Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
PLSE Pulse Biosciences Inc
- Stocks
- Healthcare
- NASDAQ: PLSE
Price (delayed)
$17.555
Market cap
$1.18B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.98
Enterprise value
$1.07B
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The CellFX® System is the first
Highlights
The quick ratio has surged by 124% year-on-year and by 31% since the previous quarter
The company's debt fell by 3.6% QoQ and by 3.6% YoY
The net income has declined by 42% year-on-year and by 12% since the previous quarter
PLSE's EPS is down by 23% year-on-year and by 7% since the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.pulsebiosciences.com
Key stats
What are the main financial stats of PLSE
Market
Valuations
Earnings
Shares outstanding
67.27M
Market cap
$1.18B
Enterprise value
$1.07B
Price to earnings (P/E)
N/A
Price to book (P/B)
9.97
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$63.69M
Net income
-$60.24M
EBIT
-$60.24M
EBITDA
-$59.08M
Free cash flow
-$40.25M
Per share
Balance sheet
Liquidity
EPS
-$0.98
EPS diluted
-$0.98
Free cash flow per share
-$0.6
Book value per share
$1.76
Revenue per share
$0
TBVPS
$1.93
Total assets
$133.38M
Total liabilities
$14.93M
Debt
$8.58M
Equity
$118.45M
Working capital
$113.15M
Debt to equity
0.07
Current ratio
15.58
Quick ratio
15.37
Net debt/EBITDA
1.87
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-60.3%
Return on equity
-71%
Return on invested capital
-543.2%
Return on capital employed
-48%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PLSE stock price
How has the Pulse Biosciences stock price performed over time
Intraday
-0.43%
1 week
-2.09%
1 month
2.12%
1 year
25.3%
YTD
0.83%
QTD
9.11%
Financial performance
How have Pulse Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$63.69M
Net income
-$60.24M
Gross margin
N/A
Net margin
N/A
The operating income has declined by 43% year-on-year and by 13% since the previous quarter
The net income has declined by 42% year-on-year and by 12% since the previous quarter
Price vs fundamentals
How does PLSE's price correlate with its fundamentals
Growth
What is Pulse Biosciences's growth rate over time
Valuation
What is Pulse Biosciences stock price valuation
P/E
N/A
P/B
9.97
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
PLSE's EPS is down by 23% year-on-year and by 7% since the previous quarter
The P/B is 27% below the last 4 quarters average of 13.7 and 18% below the 5-year quarterly average of 12.2
PLSE's equity is up by 3.1% since the previous quarter
Efficiency
How efficient is Pulse Biosciences business performance
The ROIC has dropped by 78% year-on-year and by 19% since the previous quarter
PLSE's return on equity is up by 19% year-on-year and by 15% since the previous quarter
The ROA has grown by 12% YoY and by 11% from the previous quarter
Dividends
What is PLSE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PLSE.
Financial health
How did Pulse Biosciences financials performed over time
The company's total assets has surged by 171% YoY
The quick ratio has surged by 124% year-on-year and by 31% since the previous quarter
The company's debt is 93% lower than its equity
The debt to equity has plunged by 72% YoY and by 13% from the previous quarter
The company's debt fell by 3.6% QoQ and by 3.6% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.